Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › Foundation Medicine, Chugai Partner to Bring Cancer Profiling Tests to Japan

Foundation Medicine, Chugai Partner to Bring Cancer Profiling Tests to Japan

Mar 16, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Foundation Medicine said today that it has partnered with Chugai Pharmaceutical, a member of the Roche Group, to broaden patient access to its cancer genomic profiling services in Japan.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
22
Featured Webinar

Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling

Sponsored by
Qiagen

Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology.

What's Popular?

In Cancer

  1. Oppenheimer Initiates Coverage of DermTech With Outperform Rating

  2. OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay

    Premium

  3. Natera Sues Inivata, Alleging Infringement of Cancer Testing Patents

  4. Biotheranostics' Breast Cancer Index Included in Latest NCCN Guidelines

  5. Oncocyte to Raise $25M in Stock Sale to Institutional Investors

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.